天演药业盘中异动股价大跌5.24%报16.25美元_老虎社区_美港股上老虎

天演药业盘中异动股价大跌5.24%报16.25美元

自选股智能写手2021-09-11

北京时间2021年09月11日03时57分，天演药业（ADAG.us）股票出现波动，股价大幅跳水5.24%。截至发稿，该股报16.25美元/股，成交量1.0499万股，换手率0.02%，振幅5.13%。最近的财报数据显示，该股实现营业收入702119.46美元，净利润-42.47百万美元，每股收益-1.22美元，毛利--，市盈率-11.70倍。机构评级方面，在所有3家参与评级的机构中，100%的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

Arsenzhang
·2021-09-11
啊
回复
点赞
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2166437100?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636","is_english":false,"pubTime":"2021-09-11 03:57","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2166437100","market":"us","top_or_hot":-1,"title":"天演药业盘中异动 股价大跌5.24%报16.25美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2021年09月11日03时57分，天演药业（ADAG.us）股票出现波动，股价大幅跳水5.24%。截至发稿，该股报16.25美元/股，成交量1.0499万股，换手率0.02%，振幅5.13%。最近的财报数据显示，该股实现营业收入702119.46美元，净利润-42.47百万美元，每股收益-1.22美元，毛利--，市盈率-11.70倍。机构评级方面，在所有3家参与评级的机构中，100%的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202109110357197a5b3e22&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>天演药业盘中异动 股价大跌5.24%报16.25美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n天演药业盘中异动 股价大跌5.24%报16.25美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-11 03:57 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202109110357197a5b3e22&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2021年09月11日03时57分，天演药业（ADAG.us）股票出现波动，股价大幅跳水5.24%。截至发稿，该股报16.25美元/股，成交量1.0499万股，换手率0.02%，振幅5.13%。最近的财报数据显示，该股实现营业收入702119.46美元，净利润-42.47百万美元，每股收益-1.22美元，毛利--，市盈率-11.70倍。机构评级方面，在所有3家参与评级的机构中，100%的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202109110357197a5b3e22&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ADAG","symbol_name":"天演药业","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202109110357197a5b3e22&s=b","article_id":"2166437100","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202109110357197a5b3e22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2166437100","pubTimestamp":1631303838,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2021年09月11日03时57分，天演药业股票出现波动，股价大幅跳水5.24%。截至发稿，该股报16.25美元/股，成交量1.0499万股，换手率0.02%，振幅5.13%。天演药业股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Iveric Bio Inc、Advaxis Inc、Adagio Therapeutics, Inc.涨幅较大，Iveric Bio Inc、Pharmacyte Biotech Inc、Advaxis Inc较为活跃，换手率分别为150.24%、103.43%、56.52%，振幅较大的相关个股有Advaxis Inc、Vallon Pharmaceuticals, Inc.、Iveric Bio Inc，振幅分别为40.58%、32.13%、29.34%。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"ADAG":"天演药业"},"translate_title":"Tianyan Pharmaceutical's intraday stock price fell 5.24% to US $16.25","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ADAG":1},"content_text":"北京时间2021年09月11日03时57分，天演药业（ADAG.us）股票出现波动，股价大幅跳水5.24%。截至发稿，该股报16.25美元/股，成交量1.0499万股，换手率0.02%，振幅5.13%。最近的财报数据显示，该股实现营业收入702119.46美元，净利润-42.47百万美元，每股收益-1.22美元，毛利--，市盈率-11.70倍。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。天演药业股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Iveric Bio Inc、Advaxis Inc、Adagio Therapeutics, Inc.涨幅较大，Iveric Bio Inc、Pharmacyte Biotech Inc、Advaxis Inc较为活跃，换手率分别为150.24%、103.43%、56.52%，振幅较大的相关个股有Advaxis Inc、Vallon Pharmaceuticals, Inc.、Iveric Bio Inc，振幅分别为40.58%、32.13%、29.34%。天演药业公司简介：Adagene Inc是一家平台驱动的临床阶段生物制药公司，从事转型发现和开发基于抗体的新型癌症免疫疗法。该公司的平台旨在生成具有功能性表位和物种交叉反应性的治疗性候选抗体，这一点在该公司的免疫疗法产品中得到了强调。（以上内容为自选股智能机器写手Money Call完成，仅作为用户看盘参考，不作为交易依据。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":881884451,"gmtCreate":1631324039373,"gmtModify":1631324039373,"author":{"id":"3442202405479165","authorId":"3442202405479165","name":"Arsenzhang","avatar":"https://static.tigerbbs.com/cbe05e6f56d9683fbdd98949616124f0","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3442202405479165","authorIdStr":"3442202405479165"},"htmlText":"啊","listText":"啊","text":"啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/881884451","repostId":2166437100,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}